The U.S. Food and Drug Administration approved AstraZeneca and Amgen’s drug, Tezspire, to treat severe asthma for those aged 12 years and older, the companies said on Friday. Read More
U.S. FDA Approves AstraZeneca-Amgen Drug for Severe Asthma
Market SamplerMarket Sampler
